Table 2.
Correlates of willingness to receive monkeypox vaccination.
| Variables | aOR (95% CI) | P-value |
|---|---|---|
| Sociodemographic | ||
| Age, year | ||
| <26 | Ref | |
| 26–40 | 0.90 (0.34–2.38) | 0.830 |
| >40 | 5.31 (0.30–92.53) | 0.252 |
| HIV status | ||
| Negative | Ref | |
| Positive | 0.79 (0.21–2.91) | 0.720 |
| Unknown | 4.10 (0.40–41.92) | 0.235 |
| Marital status/social relationship status | ||
| Single (unmarried, divorced or widowed) | Ref | |
| Married | 0.13 (0.03–0.47) | 0.002 |
| Cohabitation | 0.38 (0.09–1.71) | 0.208 |
| Monthly income | ||
| No fixed | Ref | |
| <2,000 | 0.41 (0.07–2.44) | 0.324 |
| 2,000-4,999 | 2.31 (0.49–10.79) | 0.289 |
| 5,000-9,999 | 0.71 (0.16–3.18) | 0.657 |
| >10,000 | 0.93 (0.13–6.76) | 0.942 |
| History of STDs | ||
| No | Ref | |
| Yes | 0.84 (0.25–2.80) | 0.771 |
| Knowledge of MPX and monkeypox vaccine | ||
| Awareness of MPX | ||
| No | Ref | |
| Yes | 0.55 (0.17–1.76) | 0.309 |
| Having good knowledge of MPX | ||
| No | Ref | |
| Yes | 2.72 (0.67–11.09) | 0.162 |
| Being considered one person could be re-infected with MPXV | ||
| Disagree | Ref | |
| Unsure | 1.61 (0.22–11.74) | 0.640 |
| Agree | 0.58 (0.09–3.85) | 0.574 |
| Being considered MSM are at high-risk population of MPXV infection | ||
| Disagree | Ref | |
| Uncertain | 0.37 (0.07–2.14) | 0.268 |
| Agree | 0.60 (0.10–3.81) | 0.590 |
| Having ever heard of smallpox (cowpox) vaccine | ||
| No | Ref | |
| Yes | 1.48 (0.34–6.46) | 0.604 |
| Worries about MPX | ||
| Worried about MPX epidemic in mainland China | ||
| Impossible | Ref | |
| Possible | 1.71 (0.46–6.42) | 0.428 |
| I do not know | 0.65 (0.18–2.41) | 0.521 |
| Worried about being infected with MPXV | ||
| Impossible | Ref | |
| Possible | 0.93 (0.27–3.16) | 0.903 |
| I do not know | 0.62 (0.18–2.10) | 0.438 |
| Worried about having sequelae after infected MPX | ||
| Impossible | Ref | |
| Possible | 1.01 (0.15–7.05) | 0.991 |
| I do not know | 2.56 (0.25–25.92) | 0.425 |
| Attitudes about monkeypox vaccination | ||
| Being considered monkeypox vaccine is safety | ||
| No | Ref | |
| Yes | 4.82 (1.35–17.18) | 0.015 |
| Do not know | 1.26 (0.29–5.49) | 0.761 |
| Being considered of the necessity for promotion of smallpox/monkeypox vaccination in China | ||
| No | Ref | |
| Yes | 6.03 (1.07–33.93) | 0.041 |
| Being considered smallpox/monkeypox vaccine should be prioritized for MSM | ||
| Disagree | Ref | |
| Unsure | 1.61 (0.37–7.10) | 0.529 |
| Agree | 5.01 (1.10–22.71) | 0.037 |
| Willing to encourage male friends or sexual partners to receive monkeypox vaccination when it was produced and nationally generalizable | ||
| Unwilling | Ref | |
| Willing | 3.19 (0.68–15.00) | 0.142 |
| Willingness to receive monkeypox or smallpox vaccination in the context of friends’ or sexual partners’ vaccination Status | ||
| Unwilling | Ref | |
| Willing | 10.37 (2.11–50.99) | 0.004 |
| Behaviors | ||
| Frequency of anal sex in the past 3 months | ||
| 3 times or below per month | Ref | |
| 4–6 times per week | 0.26 (0.09–0.77) | 0.015 |
| 4 times or above per week | 0.50 (0.12–1.99) | 0.322 |
| Having ever uptake of smallpox vaccination at birth | ||
| No | Ref | |
| Yes | 1.57 (0.50–4.92) | 0.443 |
CI: confidence interval; HIV: human immunodeficiency virus; MSM: men who have sex with men; MPXV: monkeypox virus; STDs: Sexually transmitted diseases; Ref: reference.